IDEXX Laboratories

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The Company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems for veterinarians; and biological materials testing and laboratory animal diagnostic instruments and services for biomedical research community.
It also offers diagnostic, health-monitoring, and food safety testing products for livestock, poultry, and dairy; products that test water for certain microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The Company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

Company Growth (employees)
Type
Public
HQ
Westbrook, US
Founded
1983
Size (employees)
7,365 (est)
Website
idexx.com
IDEXX Laboratories was founded in 1983 and is headquartered in Westbrook, US

IDEXX Laboratories Office Locations

IDEXX Laboratories has offices in Westbrook, Saint Petersburg, Sacramento, West Sacramento and in 24 other locations
Westbrook, US (HQ)
1 Idexx Dr
Show all (27)

IDEXX Laboratories Data and Metrics

IDEXX Laboratories Financial Metrics

IDEXX Laboratories's revenue was reported to be $462 m in Q1, 2017
USD

Revenue (Q1, 2017)

462 m

Gross profit (Q1, 2017)

258.2 m

Gross profit margin (Q1, 2017), %

56%

Net income (Q1, 2017)

69.1 m

EBIT (Q1, 2017)

92.2 m

Market capitalization (25-Jul-2017)

15 b

Cash (31-Mar-2017)

160.4 m
IDEXX Laboratories's current market capitalization is $15 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.4 b1.5 b1.6 b1.8 b

Revenue growth, %

8%8%11%

Cost of goods sold

711.6 m800 m

Gross profit

756.1 m816.1 m890.3 m975.4 m

Gross profit Margin, %

55%55%56%55%

Sales and marketing expense

317.1 m

R&D expense

101.1 m

General and administrative expense

207 m

Operating expense total

625.2 m

EBIT

266.8 m260.3 m299.9 m350.2 m

EBIT margin, %

19%18%19%20%

Interest expense

29.2 m32 m

Interest income

2.5 m3.7 m

Pre tax profit

273.1 m321.8 m

Income tax expense

81 m99.8 m

Net Income

187.8 m182 m192.1 m222.1 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

390.1 m383.5 m382.5 m413.3 m406.4 m417.6 m466.6 m448.3 m462 m

Cost of goods sold

171.6 m170.2 m166.9 m180.6 m182.1 m190 m206 m201.6 m203.8 m

Gross profit

218.5 m213.3 m215.5 m232.8 m224.3 m227.5 m260.5 m246.7 m258.2 m

Gross profit Margin, %

56%56%56%56%55%54%56%55%56%

Sales and marketing expense

68 m70.6 m75.1 m75.2 m73.1 m79.8 m76.7 m80 m87.2 m

R&D expense

25.4 m24.8 m25 m24.3 m24.9 m24.6 m25.4 m25.7 m25.8 m

General and administrative expense

41.8 m45.7 m42.6 m44.9 m46.2 m49.3 m54.3 m52.6 m52.9 m

Operating expense total

135.3 m141.1 m142.7 m144.5 m144.2 m153.7 m156.4 m158.3 m165.9 m

EBIT

83.2 m72.2 m72.8 m88.3 m71.9 m73.8 m104.2 m88.5 m92.2 m

EBIT margin, %

21%19%19%21%18%18%22%20%20%

Interest expense

(3 m)(4.3 m)(6.3 m)(7.3 m)(7.8 m)(8.3 m)(8.2 m)(7.8 m)(8.6 m)

Interest income

488 k313 k425 k559 k684 k820 k928 k851 k1.1 m

Pre tax profit

80.7 m68.2 m66.9 m81.6 m64.8 m66.3 m96.9 m81.5 m84.7 m

Income tax expense

23.5 m16 m20.3 m24.7 m20.6 m20.3 m29.7 m25.1 m15.7 m

Net Income

57.2 m52.2 m46.6 m56.9 m44.2 m46 m67.2 m56.5 m69.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

279.1 m322.5 m129 m154.9 m

Inventories

133.4 m160.3 m188.8 m158 m

Current Assets

652.7 m759.4 m821.6 m845.6 m

PP&E

281.2 m303.6 m333 m357.4 m

Goodwill

180.5 m184.5 m178.9 m178.2 m

Total Assets

1.2 b1.4 b1.5 b1.5 b

Accounts Payable

29.9 m44.7 m52.6 m60.1 m

Total Debt

151.4 m351 m593.1 m

Current Liabilities

478.4 m820.9 m856.8 m934.6 m

Non-Current Liabilities

233.9 m445.7 m702.2 m704.3 m

Total Liabilities

712.3 m1.3 b1.6 b1.6 b

Additional Paid-in Capital

825.3 m888.3 m940.5 m1 b

Retained Earnings

1.5 b1.7 b318.4 m540.4 m

Total Equity

518.2 m117.6 m(84 m)(108.2 m)

Debt to Equity Ratio

0.3 x3 x-5.5 x

Debt to Assets Ratio

0.1 x0.3 x0.4 x

Financial Leverage

2.4 x11.8 x-17.6 x-14.1 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

305 m292.7 m182.2 m163.2 m141.2 m133 m141.1 m150.1 m160.4 m

Inventories

145.4 m156 m173.4 m184.5 m192.4 m183.8 m175.7 m168.5 m172.2 m

Current Assets

701.7 m702.6 m808.9 m833 m833.4 m809 m821.1 m828.1 m878.6 m

PP&E

286.7 m291.7 m309.8 m326 m320.3 m343 m347.2 m349.7 m361.2 m

Goodwill

181.6 m176.5 m176.9 m179.7 m180.4 m181.9 m180.7 m181 m180.6 m

Total Assets

1.3 b1.3 b1.4 b1.5 b1.5 b1.5 b1.5 b1.5 b1.6 b

Accounts Payable

41.4 m58.3 m44.2 m58.2 m53.6 m52.5 m50.1 m44.1 m62.2 m

Current Liabilities

600.4 m630.3 m803.4 m775.4 m824.8 m878.7 m822.8 m760.2 m936.1 m

Non-Current Liabilities

229.9 m430.9 m593.5 m693.4 m691.2 m673.8 m675 m685.2 m709.9 m

Additional Paid-in Capital

856.4 m866.2 m912.6 m921.7 m931.8 m952.9 m972.4 m994.3 m1 b

Retained Earnings

1.6 b1.6 b1.7 b231.1 m274 m364.4 m431.6 m488 m609.4 m

Total Equity

452.9 m229.5 m34.1 m8.6 m(38.8 m)55 m

Financial Leverage

2.8 x5.6 x42 x172.8 x-38.1 x27.3 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

187.8 m182 m192.1 m222.1 m

Depreciation and Amortization

54.6 m58.9 m69 m78.2 m

Accounts Receivable

(16 m)(3.6 m)(50 m)(22.6 m)

Inventories

(1.3 m)(38 m)(35 m)7.6 m

Accounts Payable

(4.4 m)6.7 m(2.5 m)2.1 m

Cash From Operating Activities

246 m235.8 m216.4 m334.6 m

Purchases of PP&E

(77.6 m)(60.5 m)(82.9 m)(64.8 m)

Cash From Investing Activities

(86.1 m)(80.4 m)(308.4 m)(90.8 m)

Short-term Borrowings

(1.1 m)(1.4 m)(1.4 m)(1.4 m)

Cash From Financing Activities

(102.5 m)(103.4 m)(95.6 m)(217.8 m)

Interest Paid

5 m12.3 m27.2 m

Income Taxes Paid

67.7 m60.2 m54.9 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

57.2 m52.2 m46.6 m56.9 m44.2 m46 m67.2 m56.5 m69.1 m

Inventories

145.4 m156 m173.4 m184.5 m192.4 m183.8 m175.7 m168.5 m172.2 m

Accounts Payable

41.4 m58.3 m44.2 m58.2 m53.6 m52.5 m50.1 m44.1 m62.2 m
USDY, 2017

Revenue/Employee

62.7 k

IDEXX Laboratories Market Value History

IDEXX Laboratories Job Categories

IDEXX Laboratories Median Salaries

Source: 71 public H-1B filings from IDEXX Laboratories

IDEXX Laboratories Online and Social Media Presence

IDEXX Laboratories Company Life and Culture

You may also be interested in